Koopman LA - Search Results

1

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.

Boshuizen J, Koopman LA, Krijgsman O, Shahrabi A, van den Heuvel EG, Ligtenberg MA, Vredevoogd DW, Kemper K, Kuilman T, Song JY, Pencheva N, Mortensen JT, Foppen MG, Rozeman EA, Blank CU, Janmaat ML, Satijn D, Breij ECW, Peeper DS, Parren PWHI. Boshuizen J, et al. Among authors: koopman la. Nat Med. 2018 Feb;24(2):203-212. doi: 10.1038/nm.4472. Epub 2018 Jan 15. Nat Med. 2018. PMID: 29334371

2

Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer.

Koopman LA, Terp MG, Zom GG, Janmaat ML, Jacobsen K, Gresnigt-van den Heuvel E, Brandhorst M, Forssmann U, de Bree F, Pencheva N, Lingnau A, Zipeto MA, Parren PW, Breij EC, Ditzel HJ. Koopman LA, et al. JCI Insight. 2019 Nov 1;4(21):e128199. doi: 10.1172/jci.insight.128199. JCI Insight. 2019. PMID: 31600169 Free PMC article.

3

Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models.

Kemper K, Gielen E, Boross P, Houtkamp M, Plantinga TS, de Poot SA, Burm SM, Janmaat ML, Koopman LA, van den Brink EN, Rademaker R, Verzijl D, Engelberts PJ, Satijn D, Sasser AK, Breij EC. Kemper K, et al. Among authors: koopman la. Life Sci Alliance. 2022 Sep 8;5(11):e202201481. doi: 10.26508/lsa.202201481. Print 2022 Nov. Life Sci Alliance. 2022. PMID: 36271507 Free PMC article.

4

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.

Koopman LA, Corver WE, van der Slik AR, Giphart MJ, Fleuren GJ. Koopman LA, et al. J Exp Med. 2000 Mar 20;191(6):961-76. doi: 10.1084/jem.191.6.961. J Exp Med. 2000. PMID: 10727458 Free PMC article.

5

Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.

Hazelbag S, Kenter GG, Gorter A, Dreef EJ, Koopman LA, Violette SM, Weinreb PH, Fleuren GJ. Hazelbag S, et al. Among authors: koopman la. J Pathol. 2007 Jul;212(3):316-24. doi: 10.1002/path.2168. J Pathol. 2007. PMID: 17503414

6

HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines.

Koopman LA, Mulder A, Corver WE, Anholts JD, Giphart MJ, Claas FH, Fleuren GJ. Koopman LA, et al. Tissue Antigens. 1998 Jun;51(6):623-36. doi: 10.1111/j.1399-0039.1998.tb03005.x. Tissue Antigens. 1998. PMID: 9694355

7

Human leukocyte antigen class I gene mutations in cervical cancer.

Koopman LA, van Der Slik AR, Giphart MJ, Fleuren GJ. Koopman LA, et al. J Natl Cancer Inst. 1999 Oct 6;91(19):1669-77. doi: 10.1093/jnci/91.19.1669. J Natl Cancer Inst. 1999. PMID: 10511595

8

Distinction between HLA class I-positive and -negative cervical tumor subpopulations by multiparameter DNA flow cytometry.

Corver WE, Koopman LA, Mulder A, Cornelisse CJ, Fleuren GJ. Corver WE, et al. Among authors: koopman la. Cytometry. 2000 Sep 1;41(1):73-80. doi: 10.1002/1097-0320(20000901)41:1<73::aid-cyto10>3.0.co;2-5. Cytometry. 2000. PMID: 10942899 Free article.

9

Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines.

Koopman LA, Szuhai K, van Eendenburg JD, Bezrookove V, Kenter GG, Schuuring E, Tanke H, Fleuren GJ. Koopman LA, et al. Cancer Res. 1999 Nov 1;59(21):5615-24. Cancer Res. 1999. PMID: 10554043

10

Four-color multiparameter DNA flow cytometric method to study phenotypic intratumor heterogeneity in cervical cancer.

Corver WE, Koopman LA, van der Aa J, Regensburg M, Fleuren GJ, Cornelisse CJ. Corver WE, et al. Among authors: koopman la. Cytometry. 2000 Feb 1;39(2):96-107. Cytometry. 2000. PMID: 10679727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page